Financhill
Sell
38

PCVX Quote, Financials, Valuation and Earnings

Last price:
$46.98
Seasonality move :
-9.92%
Day range:
$46.58 - $47.66
52-week range:
$27.66 - $93.77
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.13x
Volume:
545.3K
Avg. volume:
1.5M
1-year change:
-45.24%
Market cap:
$6.1B
Revenue:
--
EPS (TTM):
-$4.92

Earnings Data

Next earnings date for PCVX
Feb 24
2026
Most recent earnings per share
-$1.56
Missed by $0.33
(Nov 4/2025)
Consensus Estimate
-$1.24
(Nov 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PCVX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/24/2026 Q4 -- -- -- -$1.45 --
11/04/2025 Q3 -- -- -$1.56 -$1.24 -$0.33
08/06/2025 Q2 -- -- -$1.22 -$1.16 -$0.06
05/08/2025 Q1 -- -- -$1.04 -$0.98 -$0.06
02/25/2025 Q4 -- -- -$1.10 -$0.99 -$0.11
11/05/2024 Q3 -- -- -$0.83 -$0.99 $0.16
08/06/2024 Q2 -- -- -$1.10 -$1.02 -$0.08
05/08/2024 Q1 -- -- -$0.85 -$1.06 $0.21
02/27/2024 Q4 -- -- -$1.90 -$0.99 -$0.90
11/06/2023 Q3 -- -- -$0.91 -$0.84 -$0.07
08/08/2023 Q2 -- -- -$0.70 -- --
05/08/2023 Q1 -- -- -$0.70 -- --
02/27/2023 Q4 -- -- -$1.03 -- --
11/07/2022 Q3 -- -- -$0.93 -- --
08/08/2022 Q2 -- -- -$0.80 -- --
05/09/2022 Q1 -- -- -$0.68 -- --
02/28/2022 Q4 -- -- -$0.54 -- --
11/10/2021 Q3 -- -- -$0.51 -- --
08/11/2021 Q2 -- -- -$0.46 -- --
05/11/2021 Q1 -- -- -$0.41 -- --
03/29/2021 Q4 -- -- -$0.41 -- --
11/12/2020 Q3 -- -- -$0.41 -- --
08/12/2020 Q2 -- -- -$0.40 -- --
03/31/2020 Q1 -- -- -$0.56 -- --
12/31/2019 Q4 -- -- -$0.30 -- --
09/30/2019 Q3 -- -- -$0.23 -- --
06/30/2019 Q2 -- -- -$0.21 -- --
03/31/2019 Q1 -- -- -$0.28 -- --

Vaxcyte, Inc. Earnings Questions

  • How Much did Vaxcyte, Inc. Generate in Revenue Last Quarter?

    Vaxcyte, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Vaxcyte, Inc. Beat Earnings Last Quarter?

    Vaxcyte, Inc. announced earnings per share of -$1.56 which represents a miss of analyst forecast a -$1.24 per share.

  • Is Vaxcyte, Inc. Profitable?

    Vaxcyte, Inc. reported -$5.2M that represents -$0.04 per share over the last quarter.

  • What is the Analyst Consensus for Vaxcyte, Inc. EPS Next Year?

    Vaxcyte, Inc.'s earnings are forecast to decrease from -$3.80 per share to -$3.91 per share next year representing a decrease of -39.55%.

  • When is Vaxcyte, Inc.'s Earnings Date?

    Vaxcyte, Inc.'s next earnings date is February 24, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 27

Galecto, Inc. [GLTO] is up 16.92% over the past day.

Sell
20
SMX alert for Dec 27

SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.

Sell
11
CDNAF alert for Dec 27

Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock